J B Chemicals and Pharmaceuticals
add_icon

J B Chemicals and Pharmaceuticals

1,888.60
-22.40
(-1.17%)
Market Cap
29,585.10 Cr
PE Ratio
41.64
Volume
1,25,108.00
Day High - Low
1,914.70 - 1,883.10
52W High-Low
1,939.00 - 1,385.75
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
29,585.10 Cr
EPS
42.45
PE Ratio
41.64
PB Ratio
7.86
Book Value
242.94
EBITDA
1,070.20
Dividend Yield
0.81 %
Industry
Healthcare
Return on Equity
19.21
Debt to Equity
0.06
Analyst Rating and Forecast
- By Refinitiv from9 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+66.67 %
+66.67 %
Hold
Hold+33.33 %
+33.33 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
J.B. Chemicals & Pharmaceuticals board approves additional investment of up to ₹18 crores in wholly-owned Dubai subsidiary Unique Pharmaceutical Laboratories, FZE for operational requirements.
negative
J.B. Chemicals & Pharmaceuticals receives tax demand order of ₹37 lakhs from Tamil Nadu Commercial Tax Officer for alleged ITC disallowance during FY2018-19. Company plans to file appeal.
positive
J.B. Chemicals & Pharmaceuticals Limited announced its DJSI ESG score of 86, ranking among leading pharmaceutical companies in India and globally in the sustainability index.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,729.90
#1 4,15,060.96
40.31
#1 54,729.00
9.71
#1 10,980
2.89
44.32
6,616.50
1,75,647.29
70.47
9,712.00
18.67
2,191
35.10
60.68
3,963.40
1,34,139.47
63.66
11,539.40
6.99
1,911
30.46
61.70
1,465.70
1,18,395.11
21.71
28,409.50
7.12
5,291
3.71
38.82
1,210.10
1,00,998.62
#1 17.57
33,741.20
16.73
5,725
-0.38
31.03
2,182.20
99,682.64
23.02
22,909.50
13.74
3,306
#1 72.75
63.83
2,200.80
90,850.14
52.52
12,744.20
#1 20.90
2,007
-21.05
48.57
894.90
90,047.88
18.16
23,511.00
18.55
4,615
34.60
35.88
1,198.70
69,620.69
20.49
32,345.60
9.43
3,484
3.81
48.80
5,799.00
69,335.74
28.76
13,458.30
3.70
2,216
10.98
63.14
Growth Rate
Revenue Growth
12.35 %
Net Income Growth
19.36 %
Cash Flow Change
12.72 %
ROE
1.64 %
ROCE
-3.02 %
EBITDA Margin (Avg.)
1.96 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
408
444
398
435
459
475
445
447
545
452
604
554
619
613
605
627
786
811
796
767
902
889
852
878
1,010
1,011
972
964
1,109
1,100
Expenses
326
354
304
353
350
356
339
362
367
334
377
405
442
466
473
500
612
625
618
599
664
638
621
664
724
730
709
723
793
775
EBITDA
82
90
94
81
109
119
106
85
178
119
227
149
177
146
133
127
174
186
178
168
238
251
231
215
286
281
263
241
315
325
Operating Profit %
20 %
19 %
20 %
16 %
22 %
22 %
21 %
18 %
30 %
25 %
31 %
23 %
27 %
21 %
21 %
20 %
22 %
23 %
22 %
21 %
26 %
28 %
26 %
23 %
28 %
27 %
26 %
24 %
28 %
29 %
Depreciation
15
15
15
12
16
16
17
17
17
18
17
17
18
16
17
22
26
28
28
32
31
32
34
41
41
42
42
46
43
44
Interest
1
1
1
1
1
1
1
1
4
2
1
1
1
1
1
2
6
8
8
14
12
10
13
9
6
2
3
2
1
1
Profit Before Tax
66
75
78
68
92
102
88
67
157
99
209
132
158
129
114
103
142
150
141
123
194
209
184
165
240
237
218
193
272
279
Tax
21
23
28
22
30
8
22
17
38
25
54
31
39
32
30
18
37
39
35
35
52
58
50
38
63
62
56
47
69
71
Net Profit
46
52
50
47
62
94
66
50
120
74
154
101
119
98
84
85
105
111
106
88
142
151
134
126
177
175
163
146
202
208
EPS in ₹
5.46
6.14
6.07
5.68
7.73
11.67
8.26
6.30
15.45
9.55
19.94
13.02
15.38
12.65
10.85
10.98
13.59
14.37
13.72
11.33
9.20
9.72
8.62
8.22
11.39
11.24
10.46
9.36
12.99
13.29

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
1,487
1,648
1,674
1,765
1,792
1,821
2,238
2,607
3,554
3,994
4,274
Fixed Assets
329
440
679
640
621
651
634
1,277
1,901
2,004
1,968
Current Assets
901
816
795
1,047
1,051
1,073
1,553
1,253
1,528
1,853
1,923
Capital Work in Progress
55
135
4
17
15
16
26
19
55
76
63
Investments
367
479
411
434
457
403
678
13
206
388
345
Other Assets
737
594
580
674
699
750
901
1,299
1,392
1,525
1,897
Total Liabilities
1,487
1,648
1,674
1,765
1,792
1,821
2,238
2,607
3,554
3,994
4,274
Current Liabilities
460
431
281
275
244
313
345
384
554
868
632
Non Current Liabilities
33
31
27
46
65
69
79
85
519
203
208
Total Equity
995
1,186
1,366
1,444
1,483
1,438
1,813
2,139
2,480
2,923
3,433
Reserve & Surplus
978
1,167
1,347
1,425
1,464
1,420
1,794
2,119
2,465
2,908
3,418
Share Capital
17
17
17
17
16
16
16
16
16
16
16

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
13
15
-28
43
11
-6
-3
34
20
11
27
Investing Activities
-112
-26
-45
-21
-28
24
-231
2
-962
-404
-296
Operating Activities
127
140
201
123
194
276
315
170
626
801
903
Financing Activities
-1
-100
-184
-60
-156
-306
-87
-138
357
-386
-580

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
55.91 %
55.91 %
55.91 %
54.00 %
54.00 %
54.00 %
53.96 %
53.95 %
53.93 %
53.91 %
53.86 %
53.83 %
53.78 %
53.77 %
53.74 %
53.66 %
47.84 %
47.73 %
47.56 %
47.55 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
10.05 %
0.00 %
11.06 %
12.17 %
13.63 %
14.64 %
18.30 %
17.77 %
15.30 %
14.88 %
DIIs
12.41 %
12.32 %
14.76 %
16.03 %
16.67 %
17.52 %
18.08 %
18.54 %
19.08 %
18.65 %
18.58 %
17.97 %
18.38 %
17.62 %
16.81 %
16.41 %
18.72 %
19.63 %
22.83 %
23.36 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.00 %
0.01 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
20.50 %
19.69 %
17.64 %
18.38 %
17.87 %
17.37 %
16.94 %
16.70 %
15.98 %
15.66 %
15.34 %
15.17 %
14.69 %
14.38 %
13.87 %
13.42 %
13.28 %
13.04 %
12.47 %
12.37 %
Others
11.18 %
12.08 %
11.70 %
11.58 %
11.47 %
11.10 %
11.02 %
10.81 %
11.00 %
11.79 %
2.17 %
13.03 %
2.09 %
2.05 %
1.94 %
1.87 %
1.86 %
1.83 %
1.84 %
1.85 %
No of Share Holders
0
65,715
70,740
71,788
64,861
61,314
60,268
58,629
56,633
55,965
60,817
63,230
63,892
66,953
62,743
62,081
63,948
70,064
71,957
69,338

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 1 2 5 11 16.5 16.5 17.75 12.25 15.5 0.00
Dividend Yield (%) 0.64 1.1 1.96 1.75 2.1 1.67 1.08 0.75 0.82 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
16 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
16 Jan 2026 1,818.60 1,888.60
22 Feb 2021 DIVIDEND Dividend
₹ 8.50 /share
18 Feb 2021 520.90 555.25
02 Sept 2021 DIVIDEND Dividend
₹ 8.00 /share
01 Sept 2021 770.03 850.15
24 Feb 2022 DIVIDEND Dividend
₹ 8.50 /share
23 Feb 2022 852.88 804.93
17 Aug 2022 DIVIDEND Dividend
₹ 8.00 /share
12 Aug 2022 785.18 931.68
18 Feb 2023 DIVIDEND Dividend
₹ 8.50 /share
17 Feb 2023 1,008.50 982.73
17 Aug 2023 DIVIDEND Dividend
₹ 9.25 /share
17 Aug 2023 976.00 1,315.08
24 May 2023 SPLIT Split
1:2
18 Sept 2023 976.00 976.00
16 Feb 2024 DIVIDEND Dividend
₹ 5.50 /share
16 Feb 2024 1,708.40 1,664.30
14 Aug 2024 DIVIDEND Dividend
₹ 6.75 /share
14 Aug 2024 1,832.55 1,941.60
21 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
21 Aug 2024 1,788.80 1,942.60
06 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Nov 2024 1,895.75 1,852.00
04 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Feb 2025 1,805.05 1,714.10
08 Feb 2025 DIVIDEND Dividend
₹ 8.50 /share
07 Feb 2025 1,714.10 1,673.75
14 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 May 2025 1,658.70 1,579.85
30 Jul 2025 DIVIDEND Dividend
₹ 7.00 /share
30 Jul 2025 1,579.85 1,802.60
30 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Jul 2025 1,651.85 1,802.60
06 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
06 Aug 2025 1,612.55 1,692.45
11 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2025 1,708.80 1,813.40

Announcements

Disclosure Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20153 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20184 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation5 days ago
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Receipt Of OrderDec 30, 2025
Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The Quarter And Nine Months Ending On December 31 2025Dec 29, 2025
Closure of Trading WindowDec 29, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 24, 2025
DJSI (Dow Jones Sustainable Index) ESG Score ReleaseDec 22, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Receipt Of OrderDec 16, 2025
Updates on Open OfferDec 09, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSDec 06, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 23, 2025
Updates on Open OfferNov 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 14, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 14, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 12, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 11, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 11, 2025
Board Meeting Outcome for Outcome Of Board MeetingNov 11, 2025
Letter of OfferNov 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 31, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 31, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 31, 2025
4Th Sustainability (ESG) ReportOct 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 24, 2025
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended On September 30 2025.Oct 24, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Closure of Trading WindowSep 30, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 08, 2025
Updates on Open OfferSep 04, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 01, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 31, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 14, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 11, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 06, 2025
Announcement under Regulation 30 (LODR)-Change in Registered Office AddressAug 06, 2025
Appointment Of Secretarial AuditorsAug 06, 2025
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sAug 06, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 06, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 06, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 06, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 06, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 31, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 31, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJul 30, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 30, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Franklin India Small Cap Fund Direct-Growth
0.00%
-1448723
-1.90%
-1.77%
Canara Robeco Small Cap Fund Direct - Growth
0.00%
-1353805
-1.84%
-1.71%
Franklin India Large & Mid Cap Fund Direct-Growth
0.00%
-767185
-3.67%
-3.00%
Canara Robeco ELSS Tax Saver Direct- Growth
0.00%
-574213
-1.12%
-1.06%
Kotak Small Cap Fund Direct-Growth
0.82%
-519400
-0.50%
-0.39%
Franklin India Large Cap Fund Direct-Growth
0.00%
-486932
-1.07%
-1.03%
Edelweiss Small Cap Fund Direct - Growth
0.00%
-471131
-1.57%
-1.50%
Canara Robeco Multi Cap Fund Direct - Growth
0.00%
-369649
-1.30%
-1.27%
Canara Robeco Equity Hybrid Fund Direct-Growth
0.00%
-331100
-0.51%
-0.44%
Canara Robeco Flexi Cap Fund Direct-Growth
0.00%
-321317
-0.41%
-0.39%
PGIM India Small Cap Fund Direct - Growth
0.00%
-205663
-2.28%
-2.12%
Sundaram Multi Cap Fund Direct-Growth
0.00%
-166051
-1.01%
-0.95%
Sundaram Small Cap Fund Direct-Growth
0.00%
-149333
-0.77%
-0.72%
Canara Robeco Consumer Trends Fund Direct-Growth
0.00%
-133000
-1.16%
-1.12%
Mirae Asset Small Cap Fund Direct-Growth
0.00%
-130744
-0.80%
-0.81%
Canara Robeco Manufacturing Fund Direct - Growth
0.00%
-127229
-1.37%
-1.28%
Canara Robeco Value Fund Direct - Growth
0.00%
-112254
-1.48%
-1.42%
Baroda BNP Paribas Small Cap Fund Direct - Growth
1.47%
98441
1.47%
1.47%
WhiteOak Capital Special Opportunities Fund Direct - Growth
2.88%
90364
1.16%
1.24%
Edelweiss Multi Cap Fund Direct - Growth
0.00%
-76488
-0.43%
-0.41%
WhiteOak Capital Flexi Cap Fund Direct - Growth
1.29%
64898
0.16%
0.49%
Helios Mid Cap Fund Direct-Growth
1.57%
58553
0.38%
0.88%
WhiteOak Capital Multi Asset Allocation Fund Direct - Growth
0.00%
-54191
-0.19%
-0.20%
Canara Robeco Conservative Hybrid Fund Direct-Growth
0.00%
-45000
-0.86%
-0.80%
Mirae Asset Multi Asset Allocation Fund Direct - Growth
0.00%
-43414
-0.29%
-0.29%

Technical Indicators

RSI(14)
Neutral
63.40
ATR(14)
Less Volatile
33.82
STOCH(9,6)
Overbought
84.47
STOCH RSI(14)
Neutral
71.37
MACD(12,26)
Bullish
8.69
ADX(14)
Strong Trend
27.83
UO(9)
Bearish
62.57
ROC(12)
Uptrend And Accelerating
4.65
WillR(14)
Neutral
-31.98

About J B Chemicals and Pharmaceuticals

J.B. Chemicals & Pharmaceuticals Limited is an Indian pharmaceutical company founded in 1976. It manufactures and markets a range of pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. The company specializes in gastroenterology, hypertension, and dermatology, with additional focus on nephrology, respiratory, virology, diabetes, and nicotine replacement therapy. Key brands...more
Chairperson NameArun Duggal